πŸ‡ΊπŸ‡Έ FDA
Patent

US 11723949

Modulators of complement activity

granted A61KA61K38/10A61K38/12

Quick answer

US patent 11723949 (Modulators of complement activity) held by RA PHARMACEUTICALS, INC. expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RA PHARMACEUTICALS, INC.
Grant date
Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/10, A61K38/12, A61K39/3955, A61K47/02